These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 20206173)

  • 21. Probing phenylalanine environments in oligomeric structures with pentafluorophenylalanine and cyclohexylalanine.
    Nomura T; Kamada R; Ito I; Sakamoto K; Chuman Y; Ishimori K; Shimohigashi Y; Sakaguchi K
    Biopolymers; 2011 Jun; 95(6):410-9. PubMed ID: 21280026
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modeling the relationship between the p53 C-terminal domain and its binding partners using molecular dynamics.
    Allen WJ; Capelluto DG; Finkielstein CV; Bevan DR
    J Phys Chem B; 2010 Oct; 114(41):13201-13. PubMed ID: 20873738
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The regulatory domain stabilizes the p53 tetramer by intersubunit contacts with the DNA binding domain.
    Retzlaff M; Rohrberg J; Küpper NJ; Lagleder S; Bepperling A; Manzenrieder F; Peschek J; Kessler H; Buchner J
    J Mol Biol; 2013 Jan; 425(1):144-55. PubMed ID: 23103206
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Enhancement of transcriptional activity of mutant p53 tumor suppressor protein through stabilization of tetramer formation by calix[6]arene derivatives.
    Kamada R; Yoshino W; Nomura T; Chuman Y; Imagawa T; Suzuki T; Sakaguchi K
    Bioorg Med Chem Lett; 2010 Aug; 20(15):4412-5. PubMed ID: 20605095
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Small-molecule stabilization of the p53 - 14-3-3 protein-protein interaction.
    Doveston RG; Kuusk A; Andrei SA; Leysen S; Cao Q; Castaldi MP; Hendricks A; Brunsveld L; Chen H; Boyd H; Ottmann C
    FEBS Lett; 2017 Aug; 591(16):2449-2457. PubMed ID: 28640363
    [TBL] [Abstract][Full Text] [Related]  

  • 26. NMR studies of the interaction between human programmed cell death 5 and human p53.
    Yao H; Feng Y; Zhou T; Wang J; Wang ZX
    Biochemistry; 2012 Apr; 51(13):2684-93. PubMed ID: 22372375
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Crystal structure of the p53 core domain bound to a full consensus site as a self-assembled tetramer.
    Chen Y; Dey R; Chen L
    Structure; 2010 Feb; 18(2):246-56. PubMed ID: 20159469
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Probing the alpha-helical structural stability of stapled p53 peptides: molecular dynamics simulations and analysis.
    Guo Z; Mohanty U; Noehre J; Sawyer TK; Sherman W; Krilov G
    Chem Biol Drug Des; 2010 Apr; 75(4):348-59. PubMed ID: 20331649
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cancer-associated p53 tetramerization domain mutants: quantitative analysis reveals a low threshold for tumor suppressor inactivation.
    Kamada R; Nomura T; Anderson CW; Sakaguchi K
    J Biol Chem; 2011 Jan; 286(1):252-8. PubMed ID: 20978130
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exploring the properties of small molecule protein binding via molecular simulations: the TRSH-p53 core domain complex.
    Hofer TS; van Gunsteren WF
    Mol Biosyst; 2012 Nov; 8(11):2891-900. PubMed ID: 22847335
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 14-3-3 activation of DNA binding of p53 by enhancing its association into tetramers.
    Rajagopalan S; Jaulent AM; Wells M; Veprintsev DB; Fersht AR
    Nucleic Acids Res; 2008 Oct; 36(18):5983-91. PubMed ID: 18812399
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The transient manifold structure of the p53 extreme C-terminal domain: insight into disorder, recognition, and binding promiscuity by molecular dynamics simulations.
    Fadda E; Nixon MG
    Phys Chem Chem Phys; 2017 Aug; 19(32):21287-21296. PubMed ID: 28597880
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The p53 tetramer shows an induced-fit interaction of the C-terminal domain with the DNA-binding domain.
    D'Abramo M; Bešker N; Desideri A; Levine AJ; Melino G; Chillemi G
    Oncogene; 2016 Jun; 35(25):3272-81. PubMed ID: 26477317
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adoption of a Turn Conformation Drives the Binding Affinity of p53 C-Terminal Domain Peptides to 14-3-3σ.
    Kuusk A; Neves JF; Bravo-Rodriguez K; Gunnarsson A; Ruiz-Blanco YB; Ehrmann M; Chen H; Landrieu I; Sanchez-Garcia E; Boyd H; Ottmann C; Doveston RG
    ACS Chem Biol; 2020 Jan; 15(1):262-271. PubMed ID: 31742997
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quaternary structure of p53: the light at the end of the tunnel.
    Shakked Z
    Proc Natl Acad Sci U S A; 2007 Jul; 104(30):12231-2. PubMed ID: 17640907
    [No Abstract]   [Full Text] [Related]  

  • 36. The tetramer of p53 in the absence of DNA forms a relaxed quaternary state.
    Pham N; Lucumi A; Cheung N; Viadiu H
    Biochemistry; 2012 Oct; 51(41):8053-5. PubMed ID: 23025236
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Crystal structure of a p53 core tetramer bound to DNA.
    Malecka KA; Ho WC; Marmorstein R
    Oncogene; 2009 Jan; 28(3):325-33. PubMed ID: 18978813
    [TBL] [Abstract][Full Text] [Related]  

  • 38. N-alkylated oligoamide alpha-helical proteomimetics.
    Campbell F; Plante JP; Edwards TA; Warriner SL; Wilson AJ
    Org Biomol Chem; 2010 May; 8(10):2344-51. PubMed ID: 20448891
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High-resolution structure of the p53 core domain: implications for binding small-molecule stabilizing compounds.
    Ho WC; Luo C; Zhao K; Chai X; Fitzgerald MX; Marmorstein R
    Acta Crystallogr D Biol Crystallogr; 2006 Dec; 62(Pt 12):1484-93. PubMed ID: 17139084
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tetramer formation of tumor suppressor protein p53: Structure, function, and applications.
    Kamada R; Toguchi Y; Nomura T; Imagawa T; Sakaguchi K
    Biopolymers; 2016 Nov; 106(4):598-612. PubMed ID: 26572807
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.